Results 81 to 90 of about 11,867,792 (283)

Experimental Approaches at Linear Colliders

open access: yes, 2002
This report summarises the activity of the E3 working group "Experimental Approaches at Linear Colliders". The group was charged with examining critically the physics case for a linear collider of energy of order 1 TeV as well as the cases for higher ...
Battaglia, Marco   +3 more
core   +1 more source

Evaluation of the Utility of Baseline Echocardiogram in Patients With Standard Risk Precursor B‐Lymphoblastic Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
Abstract Background A routine baseline echocardiogram is often obtained prior to anthracycline administration in children with cancer. The utility of baseline echocardiogram is unclear in patients with standard risk B‐cell acute lymphoblastic leukemia (SR B‐ALL) as their anthracycline cumulative dose is low.
Ziyad Alrajhi   +4 more
wiley   +1 more source

A Multi‐Dimensional Approach to Map Disease Relationships Challenges Classical Disease Views

open access: yesAdvanced Science
The categorization of human diseases is mainly based on the affected organ system and phenotypic characteristics. This is limiting the view to the pathological manifestations, while it neglects mechanistic relationships that are crucial to develop ...
Lena Möbus   +5 more
doaj   +1 more source

Multiscalar approaches to settlement pattern analysis [PDF]

open access: yes, 2006
This paper has emphasized the highly reflexive approach necessary for the correct identification and interpretation of the processes behind settlement patterns.
Bevan, AH, Conolly, JW
core  

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost   +10 more
wiley   +1 more source

Messianic Prophecies in the Book of Daniel: Background, Nature, and Fulfillment

open access: yesTheoRhēma, 2023
Although the book of Daniel is placed under the writings in the HB, Christ considered it prophetic (cf. Matt 24:15). From the perspective of textual exegetical analysis and otherwise, an appreciation of the (1) background, (2) nature, and (3) fulfillment
Innocent Gwizo
doaj  

Radiotherapeutic approaches

open access: yesInternational Journal of Radiation Oncology*Biology*Physics, 1979
International Journal of Radiation Oncology, Biology, Physics 5 (1979) 1027-1028. doi:10.1016/0360-3016(79)90613-8 ; Received by publisher: 0000-01-01 ; Harvest Date: 2016-01-04 12:22:16 ; DOI:10.1016/0360-3016(79)90613-8 ; Page Range: 1027 ...
Chief, Div. of Radiation Therapy, American Cancer Society Ed C. Wright Memorial Professor of Clinical Oncology, University of Florida, Gainesville, FL 32610, U.S.A. ( host institution )   +1 more
openaire   +3 more sources

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender   +17 more
wiley   +1 more source

Incidence and Risk Factors of Serious Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia: A CYP‐C Population‐Based Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteonecrosis (ON) is a debilitating complication of acute lymphoblastic leukemia (ALL) therapy. While numerous studies have explored its incidence and associated risk factors, investigations using large‐scale cohorts remain important to characterize ON across heterogeneous populations.
Noémie de Villiers   +5 more
wiley   +1 more source

New Approaches to Final Cooling

open access: yes, 2015
A high-energy muon collider scenario requires a "final cooling" system that reduces transverse emittance by a factor of ~10 while allowing longitudinal emittance increase.
Neuffer, David
core   +1 more source

Home - About - Disclaimer - Privacy